GLP-1 drugs currently being tested in China target complications associated with obesity such as heart disease, fatty liver ...

WEIGHT loss, warding off dementia, ‘curing’ diabetes and now… anti-ageing powers? Is there anything the so-called fat jabs ...

Every year, over 3,00,000 infants are born with Sickle Cell Disease (SCD) worldwide ... to Action”, led by Hindustantimes.com and HealthShots in partnership with Novo Nordisk India. Flagged off on ...

How does Innovent Biologics' mazdutide, a groundbreaking dual GLP-1/glucagon receptor drug just approved in China, compared to Wegovy and Zepbound? Read more here.

Dysregulation of the alternative complement pathway, hallmarked by isolated reduction of the serum C3 fraction, is now recognized as an additional feature of lupus nephritis. Persistent, isolated low ...